Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals [3]

Sexually Transmitted Infections

Volumn 80, Issue 2, 2004, Pages 152-153

  Kingston, M A ^a   Higgins, S P ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DOXYCYCLINE; PROCAINE PENICILLIN;

ANTIBODY TITER; DRUG RESPONSE; EPIDEMIOLOGICAL DATA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; SYPHILIS; TREATMENT OUTCOME;

EID: 1942521789     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.007179     Document Type: Letter

References (6)

1. Janier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology 1999;198:362-9.
2. Goeman J, Kivuvu M, Nzila N, et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995;71:275-9.
3. Telzak EE, Greenberg MS, Harrison J, et al. Syphilis response in HIV-infected individuals. AIDS 1991;5:591-5.
4. Yinnon AM, Coury-Doniger P, Polito R, et al. Serological response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996;156:321-5.
5. Anon. Increased transmission of syphilis in Manchester. Commun Dis Rep CDR Wkly 2000;10:89.
6. Clinical Effectiveness Group (Association of Genitourinary Medicine and Medical Society for the Study of Venereal Diseases). National guideline for the management of early syphilis. Sex Transm Infect 1999;75(Suppl 1):S29-33.